Smerdely P, Pitsiavas V, Boyages S C
Department of Clinical Endocrinology, Westmead Hospital, New South Wales, Australia.
Endocrinology. 1993 Dec;133(6):2881-8. doi: 10.1210/endo.133.6.8243315.
The thyroid gland is unique in its ability to respond to ambient levels of iodine to autoregulate thyroid function and, possibly, thyroid cell proliferation. Although the inhibitory effects of iodide on thyroid cell proliferation have been previously reported, the exact mechanism and site of action of iodide on cellular proliferation events are poorly understood. Our initial experiments established the optimal cell plating density and timing to achieve exponential cell growth of FRTL5 thyroid cells, and subsequent studies using flow cytometric DNA analysis established the normal cell cycle kinetics of FRTL5 thyroid cell proliferation. FRTL5 cells were then exposed to graded concentrations of sodium iodide to establish whether the inhibitory effects of iodide are mediated through specific cell cycle events. We observed that increasing concentrations of iodide inhibited FRTL5 thyroid cell proliferation. Analysis of the cell cycle revealed two specific effects of iodide on cell cycle kinetics. The first was an arrest of cells in G0G1, evidenced by an accumulation of cells in this phase and a concomitant reduction in the percentage of cells in the S-phase. The second was an arrest of cells in the G2M phase of the cycle. G0G1 and G2M arrest occurred within 24 h and then reached a plateau. Iodide exposure did not increase the number of cells undergoing necrosis. The addition of methimazole at two concentrations (0.2 and 2 mM) to cells exposed to 100 mM NaI prevented the accumulation of cells in G2M, but did not abolish the accumulation of cells in G0G1 or the reduction in cell number. These results indicate that the inhibitory effects of iodide on FRTL5 thyroid cell proliferation are mediated by its action at two critical regulating points of the cell cycle, G0G1 and G2M. It appears that organified iodine may mediate the cell cycle arrest in the G2M phase, whereas inorganic iodide may be responsible for the inhibitory effects at G0G1.
甲状腺在响应环境碘水平以自动调节甲状腺功能以及可能调节甲状腺细胞增殖方面具有独特能力。尽管此前已报道碘化物对甲状腺细胞增殖有抑制作用,但碘化物对细胞增殖事件的确切作用机制和作用位点仍知之甚少。我们最初的实验确定了实现FRTL5甲状腺细胞指数生长的最佳细胞接种密度和时间,随后使用流式细胞术DNA分析的研究确定了FRTL5甲状腺细胞增殖的正常细胞周期动力学。然后将FRTL5细胞暴露于分级浓度的碘化钠中,以确定碘化物的抑制作用是否通过特定的细胞周期事件介导。我们观察到,碘化钠浓度增加会抑制FRTL5甲状腺细胞增殖。细胞周期分析揭示了碘化物对细胞周期动力学的两种特定作用。第一种是细胞在G0G1期停滞,表现为该阶段细胞积累以及S期细胞百分比随之降低。第二种是细胞在细胞周期的G2M期停滞。G0G1和G2M期停滞在24小时内发生,然后达到平台期。碘化物暴露并未增加发生坏死的细胞数量。向暴露于100 mM碘化钠的细胞中添加两种浓度(0.2和2 mM)的甲巯咪唑可防止细胞在G2M期积累,但并未消除细胞在G0G1期的积累或细胞数量的减少。这些结果表明,碘化物对FRTL5甲状腺细胞增殖的抑制作用是通过其在细胞周期的两个关键调节点G0G1和G2M的作用介导的。似乎有机碘可能介导G2M期的细胞周期停滞,而无机碘化物可能是G0G1期抑制作用的原因。